Allison Landman. Show Affiliations »
Abstract
Mesh： See more » Antineoplastic Agents/therapeutic useBiomarkers, Tumor/antagonists & inhibitorsBiomarkers, Tumor/geneticsBiomarkers, Tumor/metabolismCarcinoma, Non-Small-Cell Lung/geneticsCarcinoma, Non-Small-Cell Lung/metabolismCarcinoma, Non-Small-Cell Lung/mortalityCarcinoma, Non-Small-Cell Lung/pathologyCarcinoma, Non-Small-Cell Lung/therapyChemotherapy, AdjuvantHumansLung Neoplasms/geneticsLung Neoplasms/metabolismLung Neoplasms/mortalityLung Neoplasms/pathologyLung Neoplasms/therapyMolecular Targeted TherapyPneumonectomyProtein Kinase Inhibitors/therapeutic useRisk FactorsTreatment Outcome
Substances： See more » Antineoplastic AgentsBiomarkers, TumorProtein Kinase Inhibitors
Year: 2015 PMID： 26387750 DOI： 10.1016/S1470-2045(15)00337-X
Source DB: PubMed Journal: Lancet Oncol ISSN： 1470-2045 Impact factor: 41.316